Do More With Reuters
Partner Services

Company Profile For Strides Arcolab Ltd

Strides Arcolab Ltd (STAR.BO) (Bombay Stock Exchange)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  25 Nov 2009
200.15INR
Price Change
+2.40
Percent Change
+1.21%
 
Research a stock:   symbol lookup
 

Overview

Strides Arcolab Limited is an integrated manufacturer and exporter of finished pharmaceutical dosage forms for both branded and generic. The Company’s dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semi-solids. The Company manufactures cephalosporins, beta lactams and anti TB products. The Company undertakes contract research and manufacturing of specialty chemicals. It has 13 plants in India, Singapore, Brazil, Mexico, Poland and Italy. It has marketing presence in 55 countries.

Quick Financial Synopsis

BRIEF: For the six months ended 30 June 2009, Strides Arcolab Limited revenues increased 20% to RS6.03B. Net income totalled RS523M, up from RS38M. Revenue reflects a higher sales from pharmaceutical business and an increase in other operating income. Net income also reflects a decrease in material consumed, a lower perosonnel cost, an increase in exceptional income and a higher operating margin.

Company Address

Strides Arcolab Ltd
Strides House, Billekahalli
Bannerghatta Road
Bangalore     560 076
P: +9122.27893199
F: +9122.27892942

Total Employees

1447

Find Out More About STAR.BO

Market Update

  • IndiaIndia
  • USUS
  • UKUK
  • Asia
  • Most Actives

Commodities

Commodity Last Pct Chg Trade Date/Time
Oil 78.36 +2.42% 11/26 03:31 IST
Gold 1191.6 +0.39% 11/27 04:39 IST